Anti-angiogenesis in human lymphomas. New insights.

IF 3.5 3区医学 Q2 ONCOLOGY

Frontiers in Oncology Pub Date : 2025-10-08 eCollection Date: 2025-01-01 DOI:10.3389/fonc.2025.1636332

Domenico Ribatti, Roberto Tamma, Giuseppe Ingravallo, Giorgina Specchia

引用次数: 0

Abstract

Targeting tumor angiogenesis is an advancement in the treatment of hematological malignancies. This article summarizes the most recent advancements in the use of anti-angiogenic agents in the treatment of human lymphomas. Preclinical and clinical studies have evidenced that treating lymphomas with anti-angiogenic monotherapy may not be successful. Alternative therapeutic strategies may be used to overcome resistance to anti-angiogenic therapy, including the association of different anti-angiogenic molecules or their combination with other treatment regimens.

查看原文本刊更多论文

人淋巴瘤的抗血管生成。新见解。

靶向肿瘤血管生成是血液系统恶性肿瘤治疗的一大进展。本文综述了抗血管生成药物在人淋巴瘤治疗中的最新进展。临床前和临床研究已经证明，用抗血管生成单一疗法治疗淋巴瘤可能不成功。替代治疗策略可用于克服抗血管生成治疗的耐药性，包括不同的抗血管生成分子的关联或它们与其他治疗方案的联合。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Frontiers in Oncology Biochemistry, Genetics and Molecular Biology-Cancer Research

CiteScore

6.20

自引率

10.60%

发文量

6641

审稿时长

14 weeks

期刊介绍： Cancer Imaging and Diagnosis is dedicated to the publication of results from clinical and research studies applied to cancer diagnosis and treatment. The section aims to publish studies from the entire field of cancer imaging: results from routine use of clinical imaging in both radiology and nuclear medicine, results from clinical trials, experimental molecular imaging in humans and small animals, research on new contrast agents in CT, MRI, ultrasound, publication of new technical applications and processing algorithms to improve the standardization of quantitative imaging and image guided interventions for the diagnosis and treatment of cancer.